Prescription Changes - Mpje

1. What is the federal rule for a pharmacist substituting a generic equivalent without prescriber contact?

   Permitted if state law allows and prescriber has not prohibited substitution. FD&C Act supports generic substitution for cost savings when equivalents are bioequivalent and not restricted by the prescriber.

2. What is the pharmacist's documentation duty after a prescriber-authorized change to a prescription?

   Record date/time, name of authorizer, change made, and pharmacist identity. Documentation ensures traceability and compliance with federal requirements for authorized prescription modifications.

3. What is the federal rule for a pharmacist substituting a therapeutically equivalent different drug (therapeutic interchange)?

   Not permitted without prescriber authorization unless allowed by protocol/CPA. Therapeutic interchanges involve clinical judgment on equivalence, requiring prescriber authorization unless specified in protocols.

4. Which option requires prescriber authorization: changing quantity or correcting prescriber phone number?

   Changing quantity requires prescriber authorization. Quantity modifications alter the treatment duration or amount, necessitating prescriber consent unlike simple contact detail corrections.

5. What is the federal rule for changing refills on a controlled substance prescription without prescriber authorization?

   Not permitted; refills must match prescriber authorization and law. DEA regulations enforce strict refill limits on controlled substances, requiring prescriber approval to mitigate risks of abuse and diversion.

6. Which Schedule II prescription elements may a pharmacist change after speaking with the prescriber?

   Only items DEA allows (e.g., dosage form/directions/quantity) with documentation. DEA permits limited modifications to Schedule II prescriptions post-prescriber consultation to balance flexibility with strict controls against misuse.

7. Which controlled substance schedule has the strictest federal limits on prescription changes?

   Schedule II. DEA regulations impose the most stringent controls on Schedule II substances due to their high abuse potential, limiting changes to prevent diversion.

8. What is the federal rule for changing a controlled substance prescription quantity without prescriber contact?

   Not permitted; quantity change requires prescriber authorization. Federal law classifies quantity as a therapeutic element, necessitating prescriber approval to avoid unauthorized changes in treatment dosage.

9. Identify whether changing the manufacturer (same drug/strength/form) is administrative or therapeutic.

   Administrative (if same active ingredient, strength, and dosage form). Manufacturer changes are administrative when bioequivalence is maintained, not altering the therapeutic effect under federal guidelines.

10. What is the federal rule for changing a patient address on a prescription after verification?

    Permitted as an administrative change; document the change per policy. Federal guidelines classify patient address updates as non-therapeutic corrections that pharmacists can make to improve accuracy without impacting treatment.

11. Which Schedule II prescription elements may never be changed by a pharmacist under federal law?

    Patient name, controlled substance name, and prescriber signature. DEA prohibits alterations to core identifiers on Schedule II prescriptions to safeguard against forgery and ensure accountability.

12. What prescription elements may a pharmacist change without prescriber authorization (federal rule)?

    Administrative/nonclinical items only (e.g., format); no therapy changes. Federal law allows pharmacists to modify only non-therapeutic elements like format to ensure prescription clarity without altering the intended treatment.

13. What is the federal rule for changing the directions (SIG) on any prescription without prescriber authorization?

    Not permitted; directions are a therapeutic element requiring authorization. Directions impact the therapeutic regimen, so federal rules demand prescriber authorization to ensure appropriate use and patient safety.

14. What is the federal rule for correcting or adding a missing date on a prescription?

    Requires prescriber authorization; pharmacist may document after contact. Federal rules require prescriber consent for date corrections to maintain prescription validity and prevent unauthorized dispensing.

15. Identify whether changing from tablet to capsule of the same drug/strength is administrative or therapeutic.

    Therapeutic; dosage form change requires prescriber authorization. Dosage form alterations affect drug delivery and absorption, classifying them as therapeutic changes needing prescriber approval.

16. What is the federal rule for a pharmacist adding a missing prescriber DEA number to a CS Rx?

    Requires prescriber contact/authorization and pharmacist documentation. DEA requires verification of missing DEA numbers through prescriber contact to comply with controlled substance tracking and prevent invalid dispensing.

17. What is the federal rule for changing the prescriber address or phone number on a prescription?

    Permitted if it is an administrative correction and prescriber is identified. Federal law views prescriber contact details as administrative, allowing corrections if the prescriber is verifiable to support efficient pharmacy operations.

18. Which option is allowed for Schedule II after prescriber contact: change patient name or change quantity?

    Change quantity (if prescriber authorizes and pharmacist documents). DEA allows quantity adjustments on Schedule II with prescriber approval to accommodate needs while prohibiting patient name changes to prevent fraud.

19. Which prescription changes always require prescriber authorization under federal law?

    Drug, strength, dosage form, directions, quantity, refills, patient name. Federal regulations mandate prescriber approval for alterations affecting therapy or key identifiers to prevent errors and ensure patient safety.

20. Which option is permitted without prescriber contact: correcting a misspelled patient name or changing dose?

    Correcting a misspelled patient name (administrative); dose change is not. Name corrections are administrative to ensure accurate identification, whereas dose changes impact therapy and require authorization.

21. Identify the element that cannot be altered on a Schedule II Rx even with prescriber approval: name, qty, SIG.

    Controlled substance name (drug name) cannot be changed. DEA forbids altering the controlled substance name on Schedule II prescriptions to maintain integrity and prevent substitution errors.

22. What is the federal rule for changing refills on a noncontrolled prescription without prescriber authorization?

    Not permitted; refill authorization must come from the prescriber. Federal guidelines restrict refill changes to prescriber directives to control medication access and prevent over-dispensing.

23. Which staff member may authorize a therapeutic change to a prescription (drug/strength/directions)?

    Only the prescriber (or authorized agent) or a protocol/CPA if allowed. Only prescribers or designated agents can approve therapeutic modifications under federal law to maintain medical oversight of patient care.

24. Identify the permitted action: add a missing ZIP code or add a missing drug strength to the Rx.

    Add a missing ZIP code; adding drug strength requires prescriber authorization. ZIP codes are administrative details for delivery accuracy, while drug strength is a therapeutic element requiring prescriber input.

25. What is the difference between an administrative change and a therapeutic change to a prescription?

    Administrative does not alter therapy; therapeutic changes drug regimen. Administrative changes preserve the original therapeutic intent, while therapeutic changes modify the treatment plan, requiring oversight.

Study these flashcards